检索

期
标题
作者
卷 93, 编号 12 (2021)
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G., Lopatin Y., Ametov A., Ageev F., Antsiferov M., Villevalde S., Vinogradova N., Galstyan G., Galyavich A., Gilyarevskiy S., Glezer M., Zhirov I., Ilyin M., Lebedeva A., Nedogoda S., Salukhov V., Tarlovskaya E., Tereshchenko S., Fomin I., Khalimov I., Khasanov N., Cherkashin D., Yakushin S.
PDF
(Rus)
卷 95, 编号 6 (2023)
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
PDF
(Rus)
卷 95, 编号 9 (2023)
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
PDF
(Rus)
卷 94, 编号 6 (2022)
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
PDF
(Rus)
卷 95, 编号 8 (2023)
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
PDF
(Rus)
卷 96, 编号 4 (2024)
Detection of left ventricular systolic dysfunction in patients with ischemic heart disease using spatial and frontal QRS-T angles of the electrocardiogram
Sakhnova T., Blinova E., Dotsenko Y., Uskach T., Drozdov D.
PDF
(Rus)
卷 90, 编号 8 (2018)
Efficiency of vaccine prophylaxis concentrated pneumococcal vaccine in patients with chronic obstructive lung disease and chronic heart failure
Ignatova G., Antonov V.
PDF
(Rus)
卷 88, 编号 2 (2016)
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
Drapkina O., Zyatenkova E.
PDF
(Rus)
卷 85, 编号 8 (2013)
The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
Grigor'eva N., Kuznetsov A., Koroleva T., Koroleva M.
卷 86, 编号 3 (2014)
Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease
Akhmineeva A.
卷 85, 编号 8 (2013)
Chronic obstructive pulmonary disease and comorbidities
Chuchalin A.
卷 80, 编号 8 (2008)
Beta-adrenoblockers use in combination of cardiovascular and pulmonary diseases
Makolkin V., Ovcharenko S., Litvinova I.
卷 82, 编号 2 (2010)
Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
Shoykhet Y., Klester E., Shoikhet Y., Klester E.
卷 78, 编号 10 (2003)
Syndrome ofnon-thyroid pathology in patients with cardiovascular diseases (review)
Ametov A., Balashova N., Gilyarevsky S.
卷 82, 编号 1 (2010)
The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease
Zunnunov Z., Zunnunov Z.
1 - 15 的 15 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##